Paper12410643
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.
Fischer K and 6 others. Haemophilia, 2002. Cited by 130 papers, by iCite.
Cite this record
ConductScience Library. Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen. Papers, record 12410643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12410643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Factor IX | Major topic |
| Factor VIII | Major topic |
| Hemophilia A | Major topic |
| Hemophilia B | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Dose-Response Relationship, Drug | |
| Follow-Up Studies | |
| Hemarthrosis | |
| Humans | |
| Male | |
| Quality of Life | |
| Treatment Outcome |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983703 | Long-term risk factors for hemophilic arthropathy in patients with severe hemophilia A: a 36-year retrospective cohort study. | BMC Musculoskelet Disord | 2026 | https://conductscience.org/library/papers/42983703 | PubMed |
| 41087175 | [Chinese guidelines on the treatment of hemophilia (2025)]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | https://conductscience.org/library/papers/41087175 | PubMed |
| 39565566 | Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study. | Drugs Real World Outcomes | 2024 | https://conductscience.org/library/papers/39565566 | PubMed |
| 36859289 | Successful treatment of Henoch-Schönlein purpura-associated hematochezia in a child with hemophilia A: a case report. | BMC Pediatr | 2023 | https://conductscience.org/library/papers/36859289 | PubMed |
| 36428936 | A Novel Deletion Mutation of the F8 Gene for Hemophilia A. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36428936 | PubMed |
| 35030189 | Effects of replacement therapies with clotting factors in patients with hemophilia: A systematic review and meta-analysis. | PLoS One | 2022 | https://conductscience.org/library/papers/35030189 | PubMed |
| 34703973 | Magnetic resonance imaging in boys with severe hemophilia A: Serial and end-of-study findings from the Canadian Hemophilia Primary Prophylaxis Study. | Res Pract Thromb Haemost | 2021 | https://conductscience.org/library/papers/34703973 | PubMed |
| 34168126 | Haemophilia. | Nat Rev Dis Primers | 2021 | https://conductscience.org/library/papers/34168126 | PubMed |
| 34040833 | Adherence to prophylaxis in adolescents and young adults with severe haemophilia A, a qualitative study with patients. | Health Psychol Behav Med | 2018 | https://conductscience.org/library/papers/34040833 | PubMed |
| 32467138 | Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies. | Haematologica | 2020 | https://conductscience.org/library/papers/32467138 | PubMed |
| 32196903 | FVIII activity following FVIII protein infusion or FVIII gene transfer predicts the bleeding risk in hemophilia A rats. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32196903 | PubMed |
| 31259302 | HAEMOcare: The First International Epidemiological Study Measuring Burden of Hemophilia in Developing Countries. | TH Open | 2019 | https://conductscience.org/library/papers/31259302 | PubMed |
| 29735454 | [Prophylactic treatment with low- and intermediate-dose factor VIII in children with severe hemophilia A: comprehensive evaluation of joint outcomes and correlation analysis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2018 | https://conductscience.org/library/papers/29735454 | PubMed |
| 26403578 | Scoring haemophilic arthropathy on X-rays: improving inter- and intra-observer reliability and agreement using a consensus atlas. | Eur Radiol | 2016 | https://conductscience.org/library/papers/26403578 | PubMed |
| 25177652 | Endodontic management of a haemophilic patient- a clinical perspective. | J Clin Diagn Res | 2014 | https://conductscience.org/library/papers/25177652 | PubMed |
| 25074524 | Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future. | Blood Transfus | 2014 | https://conductscience.org/library/papers/25074524 | PubMed |
| 24895637 | Psychometric properties of the Greek Haem-A-QoL for measuring quality of life in Greek haemophilia patients. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24895637 | PubMed |
| 23908669 | Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea. | Korean J Pediatr | 2013 | https://conductscience.org/library/papers/23908669 | PubMed |
| 23777770 | Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. | Blood | 2013 | https://conductscience.org/library/papers/23777770 | PubMed |
| 23149144 | Turning severe into moderate haemophilia by prophylaxis: are we reaching our goal? | Blood Transfus | 2013 | https://conductscience.org/library/papers/23149144 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12410643
GET https://conductscience.org/api/papers/v1/12410643/cited_by?page=2